Zoetis slashed full-year guidance, triggering a roughly 21.5% single-session stock decline that erased significant shareholder value. NEW YORK, May 13, 2026 /PRNewswire/ -- Zoetis Inc. (NYSE: ZTS) sha
Zoetis faces intensified US companion animal sales declines, notably from generic competition impacting key legacy drugs, Convenia and Cerenia. Despite a 30% stock drop and valuation at 12x 2026 EPS,

Zoetis: Significant Patience Required

10:17am, Saturday, 09'th May 2026
Zoetis (ZTS) faces significant competitive and pricing headwinds, with shares down 37% YTD and trading at a five-year low. ZTS reported rare misses on both top and bottom lines, driven by US companion

10 Dividend Growth Stocks: May 2025

09:00am, Saturday, 09'th May 2026
Dividend growth stocks have a streak of at least 5 consecutive years of dividend increases. I rank a selection of dividend growth stocks and present the top 10 stocks for consideration. To rank stocks
MILWAUKEE, May 7, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Zoetis (NYSE: ZTS). The investigation results from inaccurate statements Zoetis may have made
Zoetis Inc. (ZTS) Q1 2026 Earnings Call Transcript

Why Zoetis Shares Plummeted Today

02:16pm, Thursday, 07'th May 2026
Zoetis delivered sales and adjusted earnings per share growth of 3% and 9%, which was below analysts' expectations. Worse yet, its guidance for 2026 was also weak, as pet owners may be hitting a ceili
ZTS misses on Q1 earnings and cuts its 2026 revenue outlook as weaker U.S. companion animal sales pressured results, sending shares down in pre-market trading.

US Pet Care Demand Is Weak - Zoetis Cuts Outlook

01:33pm, Thursday, 07'th May 2026
Zoetis Inc. (NYSE:ZTS) shares are trading lower on Thursday as the company reports its first-quarter results.
The animal-health company missed first-quarter earnings estimates.
Although the revenue and EPS for Zoetis (ZTS) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street es
Zoetis (ZTS) came out with quarterly earnings of $1.53 per share, missing the Zacks Consensus Estimate of $1.61 per share. This compares to earnings of $1.48 per share a year ago.

Zoetis Announces First Quarter 2026 Results

07:00am, Thursday, 07'th May 2026
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS), the world's leading animal health company, today reported its financial results for the first quarter of 2026. The com
Morningstar's Investing Insights podcast recently spotlighted four S&P 500 stocks that have already declared dividend increases of 10% or more, effectively locking in their place on next year's Divide
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Zoetis (ZTS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quart
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE